# Alterome Therapeutics

**Canonical:** https://apis.io/providers/alterome-therapeutics/  
**Website:** https://www.alterome.com/  
**APIs profiled:** 0

Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San Diego, California, backed by Canaan Partners. The company designs alteration-specific cancer therapies using deep biology and chemistry expertise paired with an in-house computational chemistry platform ("The Kraken"), a custom CPU/GPU compute array for physics-based molecular simulation and drug design. Its clinical pipeline includes ALTA2618, a mutation-selective inhibitor for AKT1 E17K-driven cancers, and ALTA3263, an oral pan-KRAS ON-state inhibitor targeting more than 90% of KRAS mutations in cancer. Alterome was surfaced through the Canaan Partners portfolio and added to the API Evangelist network as a company profile; it publishes no public developer or API surface.

## Kin Score — 8.4 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 8.4).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Pharmaceuticals, Oncology, Precision Medicine, Drug Discovery, Computational Chemistry, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/alterome-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.